title: Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
authors.forename: J
authors.initials: J
authors.lastname: Narváez
authors.forename: C
authors.initials: C
authors.lastname: Díaz-Torné
authors.forename: X
authors.initials: X
authors.lastname: Juanola
authors.forename: C
authors.initials: C
authors.lastname: Geli
authors.forename: J M
authors.initials: JM
authors.lastname: Llobet
authors.forename: J M
authors.initials: JM
authors.lastname: Nolla
authors.forename: C
authors.initials: C
authors.lastname: Díaz-López
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D000069283:Rituximab; D008727:Methotrexate